A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Is Engaged In High-Level Business Development

Share
New Message
Please login to post a reply